Tyriaq Establishes Research & Development Legal Entity in Saudi Arabia

Tyriaq Establishes Research & Development Legal Entity in Saudi Arabia

Tyriaq has officially established its Research and Development legal entity in Saudi Arabia, marking a pivotal milestone in the company’s long-term commitment to advancing pharmaceutical innovation within the Kingdom and across the region.

The new entity strengthens Tyriaq’s ability to collaborate with local healthcare institutions, regulators, academic partners, and manufacturing ecosystems, aligning with national objectives such as Vision 2030 to foster local innovation and biopharmaceutical capability development.

This strategic step enables Tyriaq to accelerate its work in value-enhanced medicines, meaningful fixed-dose combinations, and the gradual development of new therapeutic solutions—co-shaping, together with healthcare stakeholders, an environment that supports home-grown scientific and clinical innovation.

Tyriaq’s presence in Saudi Arabia reinforces its dedication to building a sustainable, innovation-driven pharmaceutical footprint that delivers real value to patients and healthcare systems.